BIOT
Biotech Acquisition Company Class A Ordinary Shares
BIOT
BIOT
Delisted
BIOT was delisted on the 2nd of February, 2023.
76 hedge funds and large institutions have $218M invested in Biotech Acquisition Company Class A Ordinary Shares in 2022 Q1 according to their latest regulatory filings, with 9 funds opening new positions, 10 increasing their positions, 15 reducing their positions, and 9 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
76
Holders Change
–
Holders Change %
0%
% of All Funds
1.2%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
%
% of All Funds
0.02%
New
9
Increased
10
Reduced
15
Closed
9
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
76
UBS Group
Zurich,
Switzerland
| $9K | -$15.5K | -1,649 | -63% |
|
77
Blackstone Inc
New York
| – | -$4.92M | -500,000 | Closed |
|
|
HCM
78
Hawkeye Capital Management
Miami Beach,
Florida
| – | -$2.95M | -300,000 | Closed |
|
79
Capstone Investment Advisors
New York
| – | -$1.17M | -118,426 | Closed |
|
|
GCL
80
Glazer Capital LLC
New York
| – | -$1.09M | -110,599 | Closed |
|
|
RA
81
Ramius Advisors
New York
| – | -$984K | -100,000 | Closed |
|
|
CP
82
Centerbridge Partners
New York
| – | -$918K | -93,250 | Closed |
|
|
DFCM
83
Dark Forest Capital Management
San Juan,
Puerto Rico
| – | -$732K | -74,328 | Closed |
|
84
JPMorgan Chase & Co
New York
| – | -$492K | -50,000 | Closed |
|
85
Morgan Stanley
New York
| – | -$204K | -20,751 | Closed |
|